A value of information approach to optimal design of confirmatory clinical trials

被引：0
|
作者：
Stallard, Nigel [1 ]
Pearce, Michael [2 ]
Hee, Siew Wan [2 ]
Madan, Jason [2 ]
Posch, Martin [3 ]
Day, Simon [4 ]
Miller, Frank [5 ]
Zohar, Sarah [6 ]
机构：
[1] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[2] Univ Warwick, Coventry, W Midlands, England
[3] Med Univ Vienna, Vienna, Austria
[4] Clin Trials Consulting & Training Ltd, North Marston, England
[5] Stockholm Univ, Stockholm, Sweden
[6] INSERM, Paris, France
来源：
TRIALS | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
O46
引用
收藏
页数：2
相关论文
共 50 条
  • [31] INFORMATION AND INFORMATION FRACTIONS FOR DESIGN AND SEQUENTIAL MONITORING OF CLINICAL-TRIALS
    LAN, KKG
    REBOUSSIN, DM
    DEMETS, DL
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1994, 23 (02) : 403 - 420
  • [32] An information theoretic approach for selecting arms in clinical trials
    Mozgunov, Pavel
    Jaki, Thomas
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2020, 82 (05) : 1223 - 1247
  • [33] The clinical value of computerized information services - A review of 98 randomized clinical trials
    Balas, EA
    Austin, SM
    Mitchell, JA
    Ewigman, BG
    Bopp, KD
    Brown, GD
    ARCHIVES OF FAMILY MEDICINE, 1996, 5 (05) : 271 - 278
  • [34] Trials within trials:: Confirmatory subgroup analyses in controlled clinical experiments
    Moyé, LA
    Deswal, A
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 605 - 619
  • [35] MULTIPLE CONFIRMATORY TRIALS - HOW CAN ADDITIONAL STUDIES BE OF VALUE
    HAMILTON, JM
    ANNALS OF ONCOLOGY, 1991, 2 (09) : 625 - 627
  • [36] Optimal design of clinical trials comparing several treatments with a control
    Marschner, Ian C.
    PHARMACEUTICAL STATISTICS, 2007, 6 (01) : 23 - 33
  • [37] Bayesian Optimal Phase II Design for Randomized Clinical Trials
    Zhao, Yujie
    Yang, Bo
    Lee, J. Jack
    Wang, Li
    Yuan, Ying
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2022, 14 (04): : 423 - 432
  • [38] Optimal Design of Clinical Trials Involving Persons with Disorders of Consciousness
    Sung-Min Cho
    Chiara Robba
    Michael N. Diringer
    Daniel F. Hanley
    J. Claude Hemphill
    Janneke Horn
    Ariane Lewis
    Sarah L. Livesay
    David Menon
    Tarek Sharshar
    Robert D. Stevens
    James Torner
    Paul M. Vespa
    Wendy C. Ziai
    Marcus Spann
    Raimund Helbok
    Jose I. Suarez
    Neurocritical Care, 2024, 40 : 74 - 80
  • [39] Optimal Design of Clinical Trials Involving Persons with Disorders of Consciousness
    Cho, Sung-Min
    Robba, Chiara
    Diringer, Michael N.
    Hanley, Daniel F.
    Hemphill, J. Claude
    Horn, Janneke
    Lewis, Ariane
    Livesay, Sarah L.
    Menon, David
    Sharshar, Tarek
    Stevens, Robert D.
    Torner, James
    Vespa, Paul M.
    Ziai, Wendy C.
    Spann, Marcus
    Helbok, Raimund
    Suarez, Jose, I
    NEUROCRITICAL CARE, 2024, 40 (01) : 74 - 80
  • [40] VALUE OF PHARMACOKINETIC DATA IN DESIGN OF CLINICAL TRIALS IN BREAST CARCINOMA
    BRODER, L
    CARBONE, PP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 191 - 191
12345